Dr. Mike McClung explores the latest in osteoporosis diagnosis, fracture risk assessment, and treatment options to help women better understand and protect their bone health. This session will address who should be screened, how to interpret bone density results, when to consider medications, and how lifestyle changes can support long-term bone strength and fracture prevention.

The session will begin with a 30-minute clinical overview from Dr. McClung, followed by a 30-minute live Q&A moderated by Dr. Lisa Larkin. Dr. McClung will respond to live questions and those submitted in advance, offering practical, evidence-based insights on osteoporosis care and prevention.

Michael McClung, MD, FACP, FACE, is a board-certified endocrinologist and a globally recognized expert in osteoporosis and metabolic bone diseases. He is the Founding Director of the Oregon Osteoporosis Center and currently serves as a consultant in the development of new therapies for skeletal disorders. Dr. McClung has served as a principal investigator in numerous pivotal clinical trials and has authored more than 300 publications focused on fracture risk, bone density, and drug therapies. A sought-after speaker and research leader, he is committed to improving bone health outcomes through evidence-based screening, prevention, and treatment strategies.

Dr. Lisa Larkin, MD, FACP, MSCP, IF, will moderate the discussion, contributing her expertise in women’s preventive health and midlife care. As the founder of HERmedicine and Ms.Medicine, Dr. Larkin is committed to helping women access up-to-date, evidence-based information to guide their healthcare decisions.